Final flu vaccine effectiveness data published

Public Health England

September 11
14:30 2015

The child flu vaccine (fluenz) used in last years flu season provided good protection against circulating strains of influenza B according to a new Public Health England (PHE) study published in Eurosurveillance.

For those aged under 18 years:

  • effectiveness of the vaccine against influenza A was 35%
  • effectiveness of the vaccine against influenza B was 100%

In last years flu season, all children aged 2, 3 and 4 were offered the nasal spray child flu vaccination Fluenz, along with primary and secondary school aged children in select pilot areas across the UK.

Todays report, which is an update on previous mid-season figures on vaccine effectiveness, also found that the 2014 to 2015 adult flu vaccine used in the UK was 34% effective against the circulating strains of flu. Lower estimates of the effectiveness were calculated mid-season at 3%, however a shift in the dominant circulating strains occurred throughout the rest of the flu season. The final results showed:

  • effectiveness of the adult flu vaccine against influenza A was 29.3%
  • effectiveness of the adult flu vaccine against influenza B was 46.3%

Professor Paul Cosford, PHEs Director for Health Protection and Medical Director, said:

In recent years, we have typically seen around 50% (ranging from 25 to 70%) effectiveness for the flu vaccine in the UK, and there has generally been a good match between the strains of flu in the vaccine and those that subsequently circulate. However, last year we saw a slightly lower vaccine effectiveness than usual.

Whilst its not possible to fully predict the strains that will circulate in any given season, flu vaccination remains the best protection we have against an unpredictable virus which can cause severe illness and deaths each year among at-risk group. These include older people, pregnant women and those with a health condition, even one that is well managed.

Related Articles


  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:

Post my comment

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: